Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study.


Journal

Scandinavian journal of rheumatology
ISSN: 1502-7732
Titre abrégé: Scand J Rheumatol
Pays: England
ID NLM: 0321213

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 15 4 2020
medline: 6 10 2020
entrez: 15 4 2020
Statut: ppublish

Résumé

The complement cascade, especially the alternative pathway of complement, has been shown in basic research to be associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). We aimed to elucidate relationships between serum complement components and clinical characteristics in AAV. In a nationwide prospective cohort study (RemIT-JAV-RPGN), we measured the serum levels of C1q, C2, C3, C3b/iC3b, C4, C4b, C5, C5a, C9, factor B, factor D, factor H, factor I, mannose-binding lectin, and properdin in 52 patients with microscopic polyangiitis (MPA) and 39 patients with granulomatosis with polyangiitis (GPA). The properdin level of MPA and GPA was significantly lower than that of healthy donors. The properdin level was negatively correlated with the Birmingham Vasculitis Activity Score (BVAS) (ρ = -0.2148, p = 0.0409). The factor D level at 6 months was significantly positively correlated with the Vasculitis Damage Index (VDI) at 6, 12, and 24 months (ρ = 0.4207, 0.4132, and 0.3115, respectively). Patients with a higher ratio of C5a to C5 had higher neutrophil percentage and serum immunoglobulin G levels, and significantly lower creatinine levels. Cluster analysis divided the MPA and GPA patients into three subgroups. A principal component (PC) analysis aggregated 15 types of complements into alternative pathway-related PC 1 and complement classical pathway and common pathway-related PC 2. The serum levels of properdin and factor D were correlated with the BVAS and the VDI in MPA and GPA, respectively. Our analyses suggested the pathological heterogeneity of MPA and GPA from the aspect of complement components.

Identifiants

pubmed: 32286129
doi: 10.1080/03009742.2019.1695927
doi:

Substances chimiques

Immunosuppressive Agents 0
Complement System Proteins 9007-36-7
C-Reactive Protein 9007-41-4

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

301-311

Auteurs

S Fukui (S)

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.
Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.

K Ichinose (K)

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.

K-E Sada (KE)

Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama, Japan.

J Miyamoto (J)

Nagasaki University Hospital Clinical Research Center , Nagasaki, Japan.

M Harigai (M)

Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Department of Rheumatology, School of Medicine, Tokyo Women's Medical University , Tokyo, Japan.

K Amano (K)

Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University , Kawagoe, Japan.

T Atsumi (T)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University , Sapporo, Japan.

Y Takasaki (Y)

Department of Rheumatology, Graduate School of Medicine, Juntendo University , Tokyo, Japan.

H Dobashi (H)

Division of Endocrinology and Metabolism, Haematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University , Miki-cho, Japan.

Y Arimura (Y)

Nephrology and Rheumatology, First Department of Internal Medicine, Kyorin University School of Medicine , Tokyo, Japan.

H Hasegawa (H)

Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine , Toon, Japan.

Y Yuzawa (Y)

Department of Nephrology, Fujita Health University School of Medicine , Toyoake, Japan.

K Yamagata (K)

Department of Nephrology, Faculty of Medicine, University of Tsukuba , Tsukuba, Japan.

N Tsuboi (N)

Department of Nephrology, Internal Medicine, Nagoya University Graduate School of Medicine , Nagoya, Japan.

S Maruyama (S)

Department of Nephrology, Internal Medicine, Nagoya University Graduate School of Medicine , Nagoya, Japan.

S Matsuo (S)

Department of Nephrology, Internal Medicine, Nagoya University Graduate School of Medicine , Nagoya, Japan.

H Makino (H)

Okayama University , Okayama, Japan.

T Maeda (T)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.
Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.

A Kawakami (A)

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH